Financial Times FT.com

Resources

Principal content

Scientists used too late in crises, say MPs

Scientific advice should be used more extensively in emergencies, and not left to the last minute, MPs say. Scientists are brought in ‘too little, too late’, they say

MoD seeks damages over ‘superbug’ test

Alleged setback to worldwide efforts to accelerate diagnosis and treatment of serious infection

Sovereigns turn to pre-crisis financial wizardry

Demonised following the 2008 crisis, derivatives, along with structured finance and hedge funds, have been increasingly embraced by countries to help them out of crisis

Lombard: Lloyds’ legacy

The largest-ever voluntary pay-out agreed between a bank and the FSA will feature as a footnote to the chief executive’s swansong

Christopher Caldwell: Jeopardy is just the start

If you get paid to answer questions in a structured context, it is reasonable to fear the progeny of Watson, IBM’s quiz show-winning computer, says Christopher Caldwell

Scientists project humans into avatars

Virtual reality aims to research better pain treatments and the rehabilitation of patients with brain injury

Analysis: The perpetrators of cyber attacks

Putting a figure on how much money is lost from cyber crime is extremely difficult, largely because the victims are often unwilling to reveal that they have been targeted or say what has been taken, writes Mary Watkins

Conditional payment cure for pharma deals

The head of Sanofi-Aventis predicted more use of conditional payments in future biotechnology takeovers, as he clinched the $20bn purchase of Genzyme with a promise of up to $14 a share in cash on top of $74 upfront

Analysis: IT: Mind games

After decades of false dawns, advances in artificial intelligence are at hand – led by a digital quiz show contestant – that offer business potentially significant benefits

Judge appoints Insead’s Christoph Loch as next dean

Product innovation specialist gets top job at Cambridge

GSK looks to academia for new drugs

Eli Lilly funds aim to share research costs

Mobile technology hype cycle

Mobilising Mobility

Comment: Supply running low

Tony Jackson: Future of British science

Pfizer closure sends life sciences warning

Doubts on life sciences campus for Pfizer site

GSK sells remaining stake in Quest Diagnostics

Analysis: Spying on an industrial scale

Related content and features

Track this Topic

News alerts

Email - create a keyword alert on the subject of this topic

Email summaries

Email - start your day with daily email briefing on this topic

RSS feeds

RSS - Track this news topic using our feeds

Fourth column content

Jobs

Search
Type your search criteria below:
Recruiters

FT.com can deliver talented individuals across all industries around the world

Post a job now